Medication info
Topstatin Tablet 5mg (Rosuvastatin Calcium)

Topstatin Tablet 5mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›5.2mg / 1 tablet
Manufacturer / importer
Daehwa Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablet
Packaging
28 tablets (14 tablets/Alu-Alux2), 30 tablets/bottle
Approval status
Active

MFDS item code 201906882 · Approved 2019.09.27 · Insurance code 645605910

Summary

Main use
Treatment of dyslipidemia, inhibition of atherosclerosis progression, prevention of cardiovascular disease
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; adjust the maintenance dose if a greater reduction in LDL cholesterol is required. Most patients are controlled with a maintenance dose of 10 milligrams once daily. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams once daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal failure: No dose adjustment is necessary in patients with mild or moderate renal failure. Do not administer to patients with severe renal failure. Use particular caution when administering 20mg of this medicine to patients with moderate renal failure. 5. Patients with hepatic failure: No increase in systemic exposure to rosuvastatin was observed with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40 milligrams dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. In some of these patients, administration of the 40 milligrams dose is contraindicated.
Children's dosage
Age 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy in children have not been established.

Ingredients

Manufacturer
Daehwa Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of dyslipidemia, inhibition of atherosclerosis progression, prevention of cardiovascular disease

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • primary dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • decreased HDL cholesterol
  • smoking
  • family history of early coronary heart disease
View approved original text

This medication is helpful in cases of primary hypercholesterolemia and mixed dyslipidemia, particularly when dietary changes and exercise alone are insufficient. Additionally, it can be used in conjunction with dietary therapy or other treatments for patients with homozygous familial hypercholesterolemia, helping to lower total cholesterol and LDL cholesterol to delay the progression of atherosclerosis. It is also used as an adjunct to dietary therapy in pediatric patients aged 10 to 17 with heterozygous familial hypercholesterolemia. It is effective for patients with primary dysbetalipoproteinemia. Particularly, in high-risk groups with cardiovascular disease risk factors, it also aids in reducing the risk of stroke, myocardial infarction, and complications after revascularization procedures. Through these effects, it improves cardiovascular health.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; adjust the maintenance dose if a greater reduction in LDL cholesterol is required. Most patients are controlled with a maintenance dose of 10 milligrams once daily. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams once daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal failure: No dose adjustment is necessary in patients with mild or moderate renal failure. Do not administer to patients with severe renal failure. Use particular caution when administering 20mg of this medicine to patients with moderate renal failure. 5. Patients with hepatic failure: No increase in systemic exposure to rosuvastatin was observed with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40 milligrams dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. In some of these patients, administration of the 40 milligrams dose is contraindicated.

Children's dosage

Age 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy in children have not been established.

Precautions

It is very important not to administer this drug to certain patients. First, individuals who are allergic to any of the ingredients in this medication should not take it. Additionally, those with severely impaired liver function or unexplained elevated liver enzyme levels should also avoid this drug. Patients with muscle disorders or myopathy, as well as those taking certain immunosuppressants like cyclosporine, should avoid this medication. It is also safest not to administer it to individuals with severely reduced kidney function. Pregnant or nursing women, as well as women of childbearing age who do not use appropriate contraceptive methods, should not take this medication. Notably, patients at high risk of muscle disorders are prohibited from taking high doses, which include those with impaired kidney function, hypothyroidism, a history of genetic muscle diseases, or alcoholism. Caution is necessary for individuals with a history of liver disease or excessive alcohol consumption while taking this medication. Regular liver function tests should be performed before and during treatment, and in cases of hypercholesterolemia caused by hypothyroidism or nephrotic syndrome, the underlying cause should be treated first. If symptoms such as muscle pain, weakness, or cramps occur, medical staff should be informed immediately, and blood tests may be needed to check for muscle damage. If muscle-related symptoms are severe or if blood test results show significant increases, the medication should be discontinued. Additionally, care should be taken, as muscle damage tests may be affected after strenuous exercise. In cases of acute severe conditions such as severe infections, major surgery, or severe metabolic disorders, it is advisable to discontinue this medication. Rarely, it can cause myasthenia gravis or ocular myasthenia; therefore, if such symptoms appear, treatment should be halted. Caution is needed when used with other medications. Particularly, the co-administration with fibrate derivatives, which can increase the risk of muscle damage, is not recommended; monitoring or dose adjustments may be necessary when combined. Additionally, this drug's blood concentration may increase if taken with some antivirals, antifungals, or antibiotics, so consultation with a healthcare professional is essential. This drug can affect liver and kidney function, thus regular checkups are required. Liver enzyme levels and kidney function indicators should be periodically assessed during treatment, and if any abnormal signs are observed, medical staff should be notified promptly. Pregnant or nursing women should not take this medication, and women who could become pregnant must use appropriate contraceptive methods. If a pregnancy is planned or detected, the medication should be stopped immediately, and consultation with healthcare staff should be sought. In case of overdose, no specific antidote exists, so treatment should be symptomatic and liver function and muscle enzyme tests should be performed to manage the condition. Lastly, there may be dizziness while taking this medication, so caution should be exercised when driving or operating machinery.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, shortness of breath, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, drug rash resembling erythema multiforme, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, sensory abnormalities, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. Also, it is best to store the medication at a cool room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's efficacy and safety.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

28 tablets (14 tablets/Alu-Alux2), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.